InformerNow

Researchers at the University of Maryland have identified the gene responsible for a rare type of wheat that forms three ovaries in each flower instead of just one. Because each ovary can grow into a grain, this finding could help boost the amount of wheat produced per acre. The study appeared on October 14, 2025,…

SuperAgers are people over 80 whose memory performs as well as someone 30 years younger, showing that exceptional cognitive health can last a lifetime. They tend to be highly social, maintaining strong relationships and active lifestyles, and their brains appear to resist the buildup of Alzheimer’s-related plaques and tangles that often cause memory loss. Ongoing…

Scientists have recently captured a rare look at the harsh winter conditions swirling above Mars’ north pole. Inside the planet’s polar vortex, temperatures drop dramatically — much colder than the air outside — and the continuous darkness of the long Martian winter allows ozone levels in the atmosphere to rise sharply. “The atmosphere inside the…

Scientists at The University of Western Australia’s node of the International Centre for Radio Astronomy Research (ICRAR) have made a remarkable discovery: a massive structure stretching about 185,000 light-years between two galaxies, NGC 4532 and DDO 137, located some 53 million light-years from Earth. According to a study published in the Monthly Notices of the…

People with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of beginning immunotherapy lived considerably longer than those who did not, according to new research. Scientists from the University of Florida and the University of Texas MD Anderson Cancer Center describe this as a milestone in more than a…

Men whose prostate cancer returns after surgery or radiation therapy may soon benefit from a powerful new treatment that has been shown in clinical trials to reduce the risk of death by more than 40%. Researchers tested a therapy that combines enzalutamide, an existing cancer drug, with standard hormone therapy. This approach significantly lowered death…

Scientists at the Francis Crick Institute and Vividion Therapeutics have discovered chemical compounds that can precisely prevent the cancer-driving gene RAS from connecting with a key pathway responsible for tumor growth. The potential treatment is now moving into its first human clinical trial. If proven safe and effective, it could become a way to treat…